Injection safety

Offering a portfolio of auto-disable, reuse-prevention and sharps injury-protection injection devices

Syringe reuse has been linked to transmission of HIV, Hepatitis C and Hepatitis B. In 1999, WHO and UNICEF began to address the spread of bloodborne diseases through reuse of needles and syringes by recommending that auto-disable syringes be used for all immunisations. Since that time, auto-disable syringes have become widely accepted by the international healthcare community. With products such as the BD SoloShot™ mini syringe for immunizations as well as the BD Emerald™ PRO syringe used for curative injections, BD has also aimed to incorporate environmental stewardship into the essence of reuse prevention.

BD has also been a strong advocate for policies and guidelines, such as the recent WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in healthcare settings, which help protect healthcare workers and patients from the spread of disease.

BD devices have been used in some of the world's most critical vaccination campaigns including India's National Universal Immunization Program (UIP) over the last two decades.